Taysha Gene Therapies Inc...

NASDAQ: TSHA · Real-Time Price · USD
2.92
-0.02 (-0.68%)
At close: Aug 15, 2025, 3:59 PM
2.98
1.88%
After-hours: Aug 15, 2025, 07:17 PM EDT

Taysha Gene Therapies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-89.3M -111.57M -166.01M -174.52M
Depreciation & Amortization
1.25M 1.37M 1.17M 492K
Stock-Based Compensation
13.1M 7.91M 18.04M 18.18M
Other Working Capital
-9.55M -15.72M 26.32M 14.17M
Other Non-Cash Items
6.19M 47.28M 39.89M 10.14M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-12.47M -18.01M 18.52M 28.67M
Operating Cash Flow
-81.22M -73.02M -88.39M -117.04M
Capital Expenditures
-374K -7.37M -24.87M -21.55M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
11K -3.48M -61K n/a
Investing Cash Flow
-363K -7.35M -24.93M -21.55M
Debt Repayment
n/a -3.45M n/a 39.96M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-96K -947K -1.15M -514K
Financial Cash Flow
76.68M 136.39M 52.1M 39.08M
Net Cash Flow
-4.9M 56.02M -61.22M -99.51M
Free Cash Flow
-81.6M -80.39M -113.26M -138.6M